TY - JOUR
T1 - Central serous chorioretinopathy associated with administration of sympathomimetic agents
AU - Michael, John C.
AU - Pak, John
AU - Pulido, Jose
AU - De Venecia, Guillermo
N1 - Funding Information:
This work was supported in part by an unrestricted departmental grant from Research to Prevent Blindness, Inc. (University of Illinois at Chicago) and National Institutes of Health Core Grant EY 01792 (University of Illinois at Chicago).
PY - 2003/7/1
Y1 - 2003/7/1
N2 - PURPOSE: To report central serous chorioretinopathy associated with excessive use of compounds with sympathomimetic activity. DESIGN: Observational case series. METHODS: Four patients presented with clinical and fluorescein angiographic evidence of central serous chorioretinopathy. All patients expressed a concomitant psychogenic stress and high-dose ingestion of pseudoephedrine, oxymetazoline, or 3,4-methylenedioxymethamphetamine, all of which possess sympathomimetic properties. RESULTS: In all cases, resolution of central serous chorioretinopathy coincided with cessation of the medication. CONCLUSIONS: Patients afflicted with central serous chorioretinopathy should be notified about its possible association with sympathomimetic medications.
AB - PURPOSE: To report central serous chorioretinopathy associated with excessive use of compounds with sympathomimetic activity. DESIGN: Observational case series. METHODS: Four patients presented with clinical and fluorescein angiographic evidence of central serous chorioretinopathy. All patients expressed a concomitant psychogenic stress and high-dose ingestion of pseudoephedrine, oxymetazoline, or 3,4-methylenedioxymethamphetamine, all of which possess sympathomimetic properties. RESULTS: In all cases, resolution of central serous chorioretinopathy coincided with cessation of the medication. CONCLUSIONS: Patients afflicted with central serous chorioretinopathy should be notified about its possible association with sympathomimetic medications.
UR - http://www.scopus.com/inward/record.url?scp=0038692189&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0038692189&partnerID=8YFLogxK
U2 - 10.1016/S0002-9394(03)00076-X
DO - 10.1016/S0002-9394(03)00076-X
M3 - Article
C2 - 12834690
AN - SCOPUS:0038692189
VL - 136
SP - 182
EP - 185
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
SN - 0002-9394
IS - 1
ER -